Rosuvastatin Adherence App Study in China

NACompletedINTERVENTIONAL
Enrollment

885

Participants

Timeline

Start Date

July 20, 2015

Primary Completion Date

October 28, 2016

Study Completion Date

October 28, 2016

Conditions
DyslipidemiaHyperlipidemia
Interventions
OTHER

Smart phone based patient support tool

The smart phone application used on the patients' smart phones will contain both the patient support tool and the questions for the clinical evaluation in the form of the Rosuvastatin Adherence questionnaire (RAQ), Beliefs about Medicine Questionnaire - General (BMQ-G), (Horne, 1999) and a Lifestyle questionnaire (LSQ) on disease understanding, lifestyle and treatment awareness. Patients in the Active group will also receive feedback on their daily rosuvastatin treatment as entered in the patient support tool.

OTHER

Control application: only for data collection

the patients will have no access to the smart phone-based patient support tool. However, a smart phone application will be used to prompt patients with the questions for the clinical evaluation (RAQ, BMQ-G and LSQ).

Trial Locations (25)

100029

Research Site, Beijing

100034

Research Site, Beijing

100045

Research Site, Beijing

100049

Research Site, Beijing

100191

Research Site, Beijing

100700

Research Site, Beijing

100730

Research Site, Beijing

101199

Research Site, Beijing

200050

Research Site, Shanghai

200072

Research Site, Shanghai

200240

Research Site, Shanghai

201199

Research Site, Shanghai

261500

Research Site, Waifang

262700

Research Site, Shandong

300142

Research Site, Tianjin

300192

Research Site, Tianjin

300211

Research Site, Tianjin

310003

Research Site, Hangzhou

313003

Research Site, Huzhou

325000

Research Site, Wenzhou

330009

Research Site, Nanchang

400013

Research Site, Chongqing

410005

Research Site, Changsha

430022

Research Site, Wuhan

610041

Research Site, Chengdu

Sponsors

Lead Sponsor

All Listed Sponsors
lead

AstraZeneca

INDUSTRY